Related Experiment Video
Updated: Feb 12, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
A Novel Mechanism to Drive Castration-Resistant Prostate Cancer
Salma Kaochar1, Nicholas Mitsiades1
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Androgen receptor signaling is critical for prostate adenocarcinoma, even after androgen deprivation therapy. Persistence of intratumoral androgens has been found in castration-resistant prostate cancer and attributed to increased in situ synthesis. Recently, Sharifi and colleagues reported an additional mechanism that can enhance local androgenic exposure: downregulation of an androgen-inactivating enzyme.
Insights
Prostate cancer relies on androgen receptor signaling. Researchers found that a reduced androgen-inactivating enzyme increases local androgens, promoting cancer growth even after treatment.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Androgen receptor (AR) signaling is a key driver in prostate adenocarcinoma development and progression.
- Despite androgen deprivation therapy (ADT), persistent intratumoral androgens contribute to castration-resistant prostate cancer (CRPC).
- Increased in situ androgen synthesis is a known mechanism for intratumoral androgen persistence.
Purpose of the Study:
- To investigate alternative mechanisms contributing to local androgenic exposure in prostate cancer.
- To identify factors that enhance androgen availability in the tumor microenvironment, particularly in the context of CRPC.
Main Methods:
- The study focused on the role of androgen-inactivating enzymes.
- Investigated the impact of enzyme downregulation on local androgen levels.
- Utilized findings from Sharifi and colleagues' recent report.
Main Results:
- A novel mechanism enhancing local androgenic exposure was identified.
- Downregulation of a specific androgen-inactivating enzyme was found to increase androgen levels within the tumor.
- This enzymatic shift contributes to AR signaling in prostate cancer.
Conclusions:
- Reduced activity of androgen-inactivating enzymes represents a significant mechanism for increased local androgen availability in prostate cancer.
- Targeting these enzymes could offer new therapeutic strategies for managing CRPC.
- Understanding these pathways is crucial for overcoming treatment resistance.
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Resistivity

